{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:22:10Z","timestamp":1782512530119,"version":"3.54.5"},"reference-count":143,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.bcp.2025.116787","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T23:02:58Z","timestamp":1738364578000},"page":"116787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Potential of SIRT6 modulators in targeting molecular pathways involved in cardiovascular diseases and their treatment-A comprehensive review"],"prefix":"10.1016","volume":"233","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3880-3373","authenticated-orcid":false,"given":"Raushanara","family":"Akter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouzia","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan Shahriyer","family":"Tonmoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashfaq","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2025.116787_b0005","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: Update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.bcp.2025.116787_b0010","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2023.1207133","article-title":"The role of mammalian Sirtuin 6 in cardiovascular diseases and diabetes mellitus","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2025.116787_b0015","article-title":"Global, regional, and national death, and disability-adjusted life-years (DALYs) for cardiovascular disease in 2017 and trends and risk analysis from 1990 to 2017 using the global burden of disease study and implications for prevention","volume":"9","author":"Li","year":"2021","journal-title":"Front. Public Health"},{"key":"10.1016\/j.bcp.2025.116787_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105214","article-title":"Sirtuin 6: a potential therapeutic target for cardiovascular diseases","volume":"163","author":"Saiyang","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104626","article-title":"Therapeutic potential of polyphenols in cardiovascular diseases: Regulation of mTOR signaling pathway","volume":"152","author":"Sanches-Silva","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0030","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.3390\/biomedicines10081938","article-title":"Pathophysiology of cardiovascular diseases: new insights into molecular mechanisms of atherosclerosis, arterial hypertension, and coronary artery disease","volume":"10","author":"Fr\u0105k","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.bcp.2025.116787_b0035","first-page":"1","article-title":"Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials","volume":"7","author":"Shi","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.116787_b0040","first-page":"1","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.116787_b0045","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1161\/CIRCRESAHA.114.302022","article-title":"Mammalian target of rapamycin signaling in cardiac physiology and disease","volume":"114","author":"Sciarretta","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0050","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mTOR signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0055","first-page":"1","article-title":"Inflammation and atherosclerosis: signaling pathways and therapeutic intervention","volume":"7","author":"Kong","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.116787_b0060","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1089\/ars.2017.7178","article-title":"SIRT1 and SIRT6 signaling pathways in cardiovascular disease protection","volume":"28","author":"D\u2019Onofrio","year":"2018","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2025.116787_b0065","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1038\/nm.2961","article-title":"The sirtuin SIRT6 blocks IGF-Akt signaling and development of cardiac hypertrophy by targeting c-Jun","volume":"18","author":"Sundaresan","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.bcp.2025.116787_b0070","first-page":"1","article-title":"Multivalent interactions drive nucleosome binding and efficient chromatin deacetylation by SIRT6","volume":"11","author":"Liu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.116787_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2020.598326","article-title":"Sirt6 deacetylase: a potential key regulator in the prevention of obesity, diabetes and neurodegenerative disease","volume":"11","author":"Raj","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116787_b0080","doi-asserted-by":"crossref","first-page":"44","DOI":"10.3390\/biom8030044","article-title":"A review of the recent advances made with SIRT6 and its implications on aging related processes, major human diseases, and possible therapeutic targets","volume":"8","author":"Khan","year":"2018","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2025.116787_b0085","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.14336\/AD.2022.0413","article-title":"SIRT6 in aging, metabolism, inflammation and cardiovascular diseases","volume":"13","author":"Guo","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.bcp.2025.116787_b0090","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.tibs.2013.12.002","article-title":"Chromatin and beyond: the multitasking roles for SIRT6","volume":"39","author":"Kugel","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bcp.2025.116787_b0095","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51636","article-title":"SIRT6 is a DNA double-strand break sensor","volume":"9","author":"Onn","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.bcp.2025.116787_b0100","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1039\/c3mb00001j","article-title":"Sirtuin 6: a review of biological effects and potential therapeutic properties","volume":"9","author":"Beauharnois","year":"2013","journal-title":"Mol. Biosyst."},{"key":"10.1016\/j.bcp.2025.116787_b0105","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/j.cmet.2019.03.001","article-title":"Telomere dysfunction induces sirtuin repression that drives telomere-dependent disease","volume":"29","author":"Amano","year":"2019","journal-title":"Cell Metab."},{"key":"10.1016\/j.bcp.2025.116787_b0110","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1101\/gad.1467506","article-title":"Mammalian sirtuins\u2014emerging roles in physiology, aging, and calorie restriction","volume":"20","author":"Haigis","year":"2006","journal-title":"Genes Dev."},{"key":"10.1016\/j.bcp.2025.116787_b0115","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/nature06736","article-title":"SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin","volume":"452","author":"Michishita","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.bcp.2025.116787_b0120","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.4161\/cc.8.16.9367","article-title":"Cell cycle-dependent deacetylation of telomeric histone H3 lysine K56 by human SIRT6","volume":"8","author":"Michishita","year":"2009","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2025.116787_b0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/ncomms1443","article-title":"SIRT6 is required for maintenance of telomere position effect in human cells","volume":"2","author":"Tennen","year":"2011","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.116787_b0130","doi-asserted-by":"crossref","first-page":"11021","DOI":"10.1074\/jbc.REV120.011438","article-title":"Biological and catalytic functions of sirtuin 6 as targets for small-molecule modulators","volume":"295","author":"Klein","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116787_b0135","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1152\/physrev.00030.2018","article-title":"SIRT6, a mammalian deacylase with multitasking abilities","volume":"100","author":"Chang","year":"2020","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2025.116787_b0140","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1186231","article-title":"Sirtuin family in autoimmune diseases","volume":"14","author":"Tao","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.116787_b0145","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s10863-020-09856-2","article-title":"Downregulation of FOXO6 alleviates hypoxia-induced apoptosis and oxidative stress in cardiomyocytes by enhancing Nrf2 activation via upregulation of SIRT6","volume":"52","author":"Jin","year":"2020","journal-title":"J. Bioenerg. Biomembr."},{"key":"10.1016\/j.bcp.2025.116787_b0150","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s10565-021-09649-2","article-title":"Sirt6 protects cardiomyocytes against doxorubicin-induced cardiotoxicity by inhibiting P53\/Fas-dependent cell death and augmenting endogenous antioxidant defense mechanisms","volume":"39","author":"Wu","year":"2023","journal-title":"Cell Biol. Toxicol."},{"key":"10.1016\/j.bcp.2025.116787_b0155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.freeradbiomed.2021.01.054","article-title":"Sirtuin 6 (SIRT6) regulates redox homeostasis and signaling events in human articular chondrocytes","volume":"166","author":"Collins","year":"2021","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2025.116787_b0160","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.3390\/ijms22084180","article-title":"A comprehensive analysis into the therapeutic application of natural products as SIRT6 modulators in Alzheimer\u2019s disease, aging, cancer, inflammation, and diabetes","volume":"22","author":"Akter","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.116787_b0165","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/ijms20071599","article-title":"NFkappaB is a key player in the crosstalk between inflammation and cardiovascular diseases","volume":"20","author":"Fiordelisi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.116787_b0170","doi-asserted-by":"crossref","DOI":"10.15420\/ecr.2023.10","article-title":"Nuclear Factor-\u03baB is a prime candidate for the diagnosis and control of inflammatory cardiovascular disease","volume":"18","author":"Matsumori","year":"2023","journal-title":"Eur. Cardiol. Rev."},{"key":"10.1016\/j.bcp.2025.116787_b0175","article-title":"Inappropriate activation of TLR4\/NF-\u03baB is a cause of heart failure","volume":"7","author":"Zhou","year":"2022","journal-title":"Cardiovasc. Innov. Appl."},{"key":"10.1016\/j.bcp.2025.116787_b0180","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1152\/physrev.00054.2009","article-title":"Mitogen-activated protein kinase signaling in the heart: Angels versus demons in a heart-breaking tale","volume":"90","author":"Rose","year":"2010","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bcp.2025.116787_b0185","doi-asserted-by":"crossref","first-page":"7412","DOI":"10.3390\/ijms21197412","article-title":"p38 MAPK pathway in the heart: New insights in health and disease","volume":"21","author":"Romero-Becerra","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.116787_b0190","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/CS20070430","article-title":"MAPK signalling in cardiovascular health and disease: Molecular mechanisms and therapeutic targets","volume":"115","author":"Muslin","year":"2008","journal-title":"Clin. Sci."},{"key":"10.1016\/j.bcp.2025.116787_b0195","article-title":"Signaling pathways and targeted therapy for myocardial infarction","volume":"7","author":"Zhang","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.116787_b0200","article-title":"Calycosin as a novel PI3K activator reduces inflammation and fibrosis in heart failure through AKT\u2013IKK\/STAT3 axis","volume":"13","author":"Wang","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116787_b0205","series-title":"Transforming growth factor-\u03b2 receptors: versatile mechanisms of ligand activation","author":"Chia","year":"2024"},{"key":"10.1016\/j.bcp.2025.116787_b0210","series-title":"Dysregulations in cardiogenic mechanisms by TGF-beta and angiotensin II in cardiac remodeling post-ischemic injury: A Systematic Review","author":"Shafi","year":"2024"},{"key":"10.1016\/j.bcp.2025.116787_b0215","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.21037\/jtd.2016.11.19","article-title":"The role of transforming growth factor (TGF)-\u03b2 in the infarcted myocardium","volume":"9","author":"Frangogiannis","year":"2017","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.bcp.2025.116787_b0220","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/hr.2009.187","article-title":"The role of AMP-activated protein kinase in the cardiovascular system","volume":"33","author":"Nagata","year":"2009","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0225","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1161\/CIRCRESAHA.111.255505","article-title":"AMP-activated protein kinase regulation and biological actions in the heart","volume":"111","author":"Zaha","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0230","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/aps.2010.139","article-title":"AMPK in cardiovascular health and disease","volume":"31","author":"Shirwany","year":"2010","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2025.116787_b0235","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-02795-4","article-title":"AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation","volume":"9","author":"G\u00e9linas","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.116787_b0240","article-title":"Hypoxia-inducible factors as central players in the pathogenesis and pathophysiology of cardiovascular diseases","volume":"8","author":"Rojas","year":"2021","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bcp.2025.116787_b0245","article-title":"Hypoxia-induced signaling in the cardiovascular system: Pathogenesis and therapeutic targets","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.116787_b0250","doi-asserted-by":"crossref","DOI":"10.53941\/ijddp.2024.100016","article-title":"Unraveling the roles of HIF-1, HO-1, GLUT-1 and GLUT-4 in myocardial protection","author":"Chong","year":"2024","journal-title":"Int. J. Drug Discov. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116787_b0255","article-title":"Novel therapeutic targets for hypoxia-related cardiovascular diseases: The role of HIF-1","volume":"11","author":"Liu","year":"2020","journal-title":"Front. Physiol."},{"key":"10.1016\/j.bcp.2025.116787_b0260","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1093\/eurheartj\/ehab447","article-title":"The JAK\u2013STAT pathway: An emerging target for cardiovascular disease in rheumatoid arthritis and myeloproliferative neoplasms","volume":"42","author":"Baldini","year":"2021","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2025.116787_b0265","article-title":"The JAK\/STAT signaling pathway: From bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.bcp.2025.116787_b0270","article-title":"JAK\/STAT3 signaling in cardiac fibrosis: A promising therapeutic target","volume":"15","author":"Jiang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116787_b0275","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1157043","article-title":"The role of \u03b2-catenin in cardiac diseases","volume":"14","author":"Ni","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116787_b0280","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.695114","article-title":"Adding a \u201cNotch\u201d to cardiovascular disease therapeutics: A MicroRNA-based approach","volume":"9","author":"Marracino","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2025.116787_b0285","doi-asserted-by":"crossref","DOI":"10.3892\/ijmm.2023.5230","article-title":"Role of the Notch1 signaling pathway in ischemic heart disease (Review)","volume":"51","author":"Peng","year":"2023","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.bcp.2025.116787_b0290","doi-asserted-by":"crossref","first-page":"6863","DOI":"10.3390\/ijms14046863","article-title":"Impact of Notch signaling on inflammatory responses in cardiovascular disorders","volume":"14","author":"Quillard","year":"2013","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2025.116787_b0295","article-title":"Notch signaling regulates immune responses in atherosclerosis","volume":"10","author":"Sega","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bcp.2025.116787_b0300","article-title":"The role of Notch pathway in cardiovascular diseases","author":"Aquila","year":"2013","journal-title":"PubMed"},{"key":"10.1016\/j.bcp.2025.116787_b0310","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.907348","article-title":"Modulation of mTOR signaling in cardiovascular disease to target acute and chronic inflammation","volume":"9","author":"Kaldirim","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bcp.2025.116787_b0315","first-page":"129","article-title":"mTOR in the mechanisms of atherosclerosis and cardiovascular disease","volume":"31","author":"Liu","year":"2021","journal-title":"Discov. Med."},{"key":"10.1016\/j.bcp.2025.116787_b0320","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s12265-020-10049-w","article-title":"Immunomodulation of the NLRP3 inflammasome in atherosclerosis, coronary artery disease, and acute myocardial infarction","volume":"14","author":"Silvis","year":"2020","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0325","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.927061","article-title":"NLRP3 inflammasome: The rising star in cardiovascular diseases","volume":"9","author":"Zheng","year":"2022","journal-title":"Front. Cardiovasc. Med."},{"key":"10.1016\/j.bcp.2025.116787_b0330","first-page":"1","article-title":"NLRP3 inflammasome and its central role in cardiovascular diseases","volume":"2020","author":"Tong","year":"2020","journal-title":"Oxid. Med. Cell Longev."},{"key":"10.1016\/j.bcp.2025.116787_b0335","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00395-016-0531-z","article-title":"SIRT6 protects cardiomyocytes against ischemia\/reperfusion injury by augmenting FoxO3\u03b1-dependent antioxidant defense mechanisms","volume":"111","author":"Wang","year":"2016","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.bcp.2025.116787_b0340","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.3389\/fphar.2018.01519","article-title":"SIRT6 suppresses NFATc4 expression and activation in cardiomyocyte hypertrophy","volume":"9","author":"Li","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116787_b0345","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-018-0007-y","article-title":"Mechanisms of physiological and pathological cardiac hypertrophy","volume":"15","author":"Nakamura","year":"2018","journal-title":"Nat. Rev. Cardiol."},{"key":"10.1016\/j.bcp.2025.116787_b0350","doi-asserted-by":"crossref","first-page":"9115","DOI":"10.1093\/nar\/gkz648","article-title":"SIRT6 transcriptionally regulates global protein synthesis through transcription factor Sp1 independent of its deacetylase activity","volume":"47","author":"Ravi","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bcp.2025.116787_b0355","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1093\/cvr\/cvs352","article-title":"SIRT6 protects human endothelial cells from DNA damage, telomere dysfunction, and senescence","volume":"97","author":"Cardus","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0360","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.18632\/aging.100975","article-title":"SIRT6 protects against endothelial dysfunction and atherosclerosis in mice","volume":"8","author":"Xu","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2025.116787_b0365","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1139\/bcb-2019-0057","article-title":"Sirt6 stabilizes atherosclerosis plaques by promoting macrophage autophagy and reducing contact with endothelial cells","volume":"98","author":"Wang","year":"2020","journal-title":"Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2025.116787_b0370","doi-asserted-by":"crossref","DOI":"10.1016\/j.trsl.2016.02.005","article-title":"Deletion of sirtuin 6 accelerates endothelial dysfunction and atherosclerosis in apolipoprotein E-deficient mice","volume":"172","author":"Liu","year":"2016","journal-title":"Transl. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0375","doi-asserted-by":"crossref","first-page":"20946","DOI":"10.18632\/aging.202176","article-title":"Sirtuin 6 deficiency induces endothelial cell senescence via downregulation of forkhead box M1 expression","volume":"12","author":"Lee","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2025.116787_b0380","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41419-020-03372-2","article-title":"SIRT6 promotes angiogenesis and hemorrhage of carotid plaque via regulating HIF-1\u03b1 and reactive oxygen species","volume":"12","author":"Yang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.116787_b0385","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/eurheartj\/ehu179","article-title":"Targeting prolyl-isomerase Pin1 prevents mitochondrial oxidative stress and vascular dysfunction: insights in patients with diabetes","volume":"36","author":"Paneni","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2025.116787_b0390","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/597514","article-title":"Anti-inflammatory properties of sirtuin 6 in human umbilical vein endothelial cells","volume":"2012","author":"Lappas","year":"2012","journal-title":"Mediators Inflamm."},{"key":"10.1016\/j.bcp.2025.116787_b0395","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.2337\/db14-1149","article-title":"Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment","volume":"64","author":"Balestrieri","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.bcp.2025.116787_b0400","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.yjmcc.2020.01.002","article-title":"Sirt6 deletion in bone marrow-derived cells increases atherosclerosis - Central role of macrophage scavenger receptor 1","volume":"139","author":"Arsiwala","year":"2020","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.bcp.2025.116787_b0405","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1161\/CIRCRESAHA.120.318353","article-title":"SIRT6 protects smooth muscle cells from senescence and reduces atherosclerosis","volume":"128","author":"Grootaert","year":"2021","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0410","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.biocel.2014.01.016","article-title":"The role of SIRT6 in the differentiation of vascular smooth muscle cells in response to cyclic strain","volume":"49","author":"Yao","year":"2014","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.bcp.2025.116787_b0415","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1161\/CIRCRESAHA.118.314032","article-title":"Endothelial SIRT6 is vital to prevent hypertension and associated cardiorenal injury through targeting Nkx3.2-GATA5 signaling","volume":"124","author":"Guo","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0420","doi-asserted-by":"crossref","first-page":"8835","DOI":"10.1038\/ncomms9835","article-title":"Endothelial Gata5 transcription factor regulates blood pressure","volume":"6","author":"Messaoudi","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bcp.2025.116787_b0770","unstructured":"Endothelial Cells. PromoCell https:\/\/promocell.com\/cell-culture-basics\/endothelial-cells\/."},{"key":"10.1016\/j.bcp.2025.116787_b0425","article-title":"Icariin intervenes in cardiac inflammaging through upregulation of SIRT6 enzyme activity and inhibition of the NF-kappa B pathway","volume":"2015","author":"Chen","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2025.116787_b0430","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1002\/kjm2.12219","article-title":"MiR-370 accelerated cerebral ischemia reperfusion injury via targeting SIRT6 and regulating Nrf2\/ARE signal pathway","volume":"36","author":"Ruan","year":"2020","journal-title":"Kaohsiung J. Med. Sci."},{"key":"10.1016\/j.bcp.2025.116787_b0435","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yexcr.2014.07.013","article-title":"Sirtuin 6 protects the heart from hypoxic damage","volume":"330","author":"Maksin-Matveev","year":"2015","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2025.116787_b0440","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1089\/ars.2011.4487","article-title":"Inhibition of nicotinamide phosphoribosyltransferase reduces neutrophil-mediated injury in myocardial infarction","volume":"18","author":"Montecucco","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bcp.2025.116787_b0445","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12698","article-title":"Melatonin attenuates diabetic cardiomyopathy and reduces myocardial vulnerability to ischemia-reperfusion injury by improving mitochondrial quality control: Role of SIRT6","volume":"70","author":"Yu","year":"2021","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bcp.2025.116787_b0450","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1093\/eurheartj\/ehz712","article-title":"Endothelial SIRT6 blunts stroke size and neurological deficit by preserving blood-brain barrier integrity: a translational study","volume":"41","author":"Liberale","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.bcp.2025.116787_b0455","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1016\/j.apsb.2020.11.002","article-title":"A novel SIRT6 activator ameliorates neuroinflammation and ischemic brain injury via EZH2\/FOXC1 axis","volume":"11","author":"He","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2025.116787_b0460","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.14336\/AD.2021.1204","article-title":"SIRT6 in vascular diseases, from bench to bedside","volume":"13","author":"Ren","year":"2022","journal-title":"Aging Dis."},{"key":"10.1016\/j.bcp.2025.116787_b0465","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1007\/s12265-021-10184-y","article-title":"SIRT6 Protects against myocardial ischemia-reperfusion injury by attenuating aging-related CHMP2B accumulation","volume":"15","author":"Li","year":"2022","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0775","unstructured":"SIRT6 protein overview: sequence, structure, and function. SinoBiological https:\/\/www.sinobiological.com\/resource\/sirt6\/proteins."},{"key":"10.1016\/j.bcp.2025.116787_b0470","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1089\/gtmb.2015.0188","article-title":"Sequence variants of SIRT6 gene promoter in myocardial infarction","volume":"20","author":"Wang","year":"2016","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.bcp.2025.116787_b0475","doi-asserted-by":"crossref","first-page":"904","DOI":"10.3390\/biomedicines9080904","article-title":"Metformin therapy effects on the expression of sodium-glucose cotransporter 2, leptin, and SIRT6 Levels in pericoronary fat excised from pre-diabetic patients with acute myocardial infarction","volume":"9","author":"Sardu","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/j.bcp.2025.116787_b0480","doi-asserted-by":"crossref","first-page":"277","DOI":"10.17219\/acem\/112060","article-title":"Melatonin protected against myocardial infarction injury in rats through a Sirt6-dependent antioxidant pathway","volume":"31","author":"Wang","year":"2022","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.bcp.2025.116787_b0485","article-title":"SIRT6 in senescence and aging-related cardiovascular diseases","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.bcp.2025.116787_b0490","first-page":"1","article-title":"Oxidative stress induces endothelial cell senescence via downregulation of Sirt6","volume":"2014","author":"Liu","year":"2014","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.bcp.2025.116787_b0495","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/15384101.2016.1152427","article-title":"Calorie restriction-induced SIRT6 activation delays aging by suppressing NF-\u03baB signaling","volume":"15","author":"Zhang","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2025.116787_b0500","doi-asserted-by":"crossref","first-page":"12334","DOI":"10.18632\/aging.203027","article-title":"The nuclear sirtuin SIRT6 protects the heart from developing aging-associated myocyte senescence and cardiac hypertrophy","volume":"13","author":"Pillai","year":"2021","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bcp.2025.116787_b0505","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/CIRCRESAHA.117.311045","article-title":"EphrinB2 regulates cardiac Fibrosis through modulating the interaction of Stat3 and TGF-\u03b2\/Smad3 signaling","volume":"121","author":"Su","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0510","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","article-title":"Cardiac fibrosis: the fibroblast awakens","volume":"118","author":"Travers","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0515","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1074\/jbc.RA118.007212","article-title":"Sirtuin 6 deficiency transcriptionally up-regulates TGF-\u03b2 signaling and induces fibrosis in mice","volume":"295","author":"Maity","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116787_b0520","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.trsl.2014.08.008","article-title":"Sirtuin-6 inhibits cardiac fibroblasts differentiation into myofibroblasts via inactivation of nuclear factor \u03baB signaling","volume":"165","author":"Tian","year":"2015","journal-title":"Transl. Res."},{"key":"10.1016\/j.bcp.2025.116787_b0525","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3389\/fphar.2020.01150","article-title":"Exogenous hydrogen sulfide ameliorates diabetic myocardial fibrosis by inhibiting cell aging through SIRT6\/AMPK autophagy","volume":"11","author":"Li","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2025.116787_b0530","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.1096\/fj.201900767R","article-title":"The nuclear and mitochondrial sirtuins, Sirt6 and Sirt3, regulate each other\u2019s activity and protect the heart from developing obesity-mediated diabetic cardiomyopathy","volume":"33","author":"Kanwal","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2025.116787_b0535","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.2147\/DMSO.S287287","article-title":"Sirt6-mediated endothelial-to-mesenchymal transition contributes toward diabetic cardiomyopathy via the Notch1 signaling pathway","volume":"13","author":"Zhang","year":"2020","journal-title":"Diabetes. Metab. Syndr. Obes."},{"key":"10.1016\/j.bcp.2025.116787_b0540","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3892\/mmr.2021.12006","article-title":"SIRT6\u2011specific inhibitor OSS\u2011128167 exacerbates diabetic cardiomyopathy by aggravating inflammation and oxidative stress","volume":"23","author":"Huang","year":"2021","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bcp.2025.116787_b0780","unstructured":"Gross Anatomy Of The Human Heart Postcard. Zazzle https:\/\/www.zazzle.com\/gross_anatomy_of_the_human_heart_postcard-239111369163473518."},{"key":"10.1016\/j.bcp.2025.116787_b0545","doi-asserted-by":"crossref","first-page":"7465","DOI":"10.7150\/thno.45003","article-title":"Sirt6 deficiency aggravates angiotensin II-induced cholesterol accumulation and injury in podocytes","volume":"10","author":"Yang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2025.116787_b0550","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexcr.2021.112526","article-title":"Protective effect of SIRT6 on cholesterol crystal-induced endothelial dysfunction via regulating ACE2 expression","volume":"402","author":"Zheng","year":"2021","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.bcp.2025.116787_b0555","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.3390\/cancers13051156","article-title":"The two-faced role of SIRT6 in cancer","volume":"13","author":"Fiorentino","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.bcp.2025.116787_b0560","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/s41589-018-0150-0","article-title":"Identification of a cellularly active SIRT6 allosteric activator","volume":"14","author":"Huang","year":"2018","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.bcp.2025.116787_b0625","doi-asserted-by":"crossref","first-page":"4163","DOI":"10.1038\/s41598-018-22388-5","article-title":"Natural polyphenols as sirtuin 6 modulators","volume":"8","author":"Rahnasto-Rilla","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.116787_b0630","doi-asserted-by":"crossref","first-page":"19176","DOI":"10.1038\/s41598-019-55654-1","article-title":"Structural basis for the activation and inhibition of Sirtuin 6 by quercetin and its derivatives","volume":"9","author":"You","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.116787_b0635","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.freeradbiomed.2016.04.013","article-title":"Ergothioneine oxidation in the protection against high-glucose induced endothelial senescence: involvement of SIRT1 and SIRT6","volume":"96","author":"D\u2019Onofrio","year":"2016","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bcp.2025.116787_b0640","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7374086","article-title":"Chrysophanol alleviates metabolic syndrome by activating the SIRT6\/AMPK signaling pathway in brown adipocytes","volume":"2020","author":"Liu","year":"2020","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.bcp.2025.116787_b0645","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1038\/s41401-020-0442-2","article-title":"MDL-800, an allosteric activator of SIRT6, suppresses proliferation and enhances EGFR-TKIs therapy in non-small cell lung cancer","volume":"42","author":"Shang","year":"2021","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.bcp.2025.116787_b0650","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1002\/hep.31418","article-title":"Sirt6 alleviated liver fibrosis by deacetylating conserved lysine 54 on Smad2 in hepatic stellate cells","volume":"73","author":"Zhang","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.bcp.2025.116787_b0655","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.apsb.2020.09.010","article-title":"Mechanism of allosteric activation of SIRT6 revealed by the action of rationally designed activators","volume":"11","author":"Lu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bcp.2025.116787_b0660","doi-asserted-by":"crossref","first-page":"5845","DOI":"10.7150\/thno.44043","article-title":"Small-molecule activating SIRT6 elicits therapeutic effects and synergistically promotes anti-tumor activity of vitamin D3 in colorectal cancer","volume":"10","author":"Shang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.bcp.2025.116787_b0665","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/anie.201610082","article-title":"Structural basis of sirtuin 6 activation by synthetic small molecules","volume":"56","author":"You","year":"2017","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"10.1016\/j.bcp.2025.116787_b0670","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1038\/s41419-018-1065-0","article-title":"Pharmacological activation of SIRT6 triggers lethal autophagy in human cancer cells","volume":"9","author":"Iachettini","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bcp.2025.116787_b0675","doi-asserted-by":"crossref","first-page":"469","DOI":"10.3892\/etm.2022.11396","article-title":"Luteolin suppresses TNF-\u03b1-induced inflammatory injury and senescence of nucleus pulposus cells via the Sirt6\/NF-\u03baB pathway","volume":"24","author":"Xie","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bcp.2025.116787_b0680","doi-asserted-by":"crossref","first-page":"7772","DOI":"10.1038\/s41598-022-11761-0","article-title":"Resveratrol blocks retrotransposition of LINE-1 through PPAR \u03b1 and sirtuin-6","volume":"12","author":"Okudaira","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bcp.2025.116787_b0685","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0021-9258(17)49896-6","article-title":"Mechanism of activation for the sirtuin 6 protein deacylase","volume":"295","author":"Klein","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116787_b0690","doi-asserted-by":"crossref","first-page":"31350","DOI":"10.1074\/jbc.C113.511261","article-title":"Activation of the protein deacetylase SIRT6 by long-chain fatty acids and widespread deacylation by mammalian sirtuins","volume":"288","author":"Feldman","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116787_b0695","doi-asserted-by":"crossref","first-page":"9732","DOI":"10.1021\/acs.jmedchem.1c00601","article-title":"Emerging therapeutic potential of SIRT6 modulators","volume":"64","author":"Fiorentino","year":"2021","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.116787_b0700","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cbic.201500482","article-title":"N-Acylethanolamines bind to SIRT6","volume":"17","author":"Rahnasto-Rilla","year":"2016","journal-title":"Chembiochem"},{"key":"10.1016\/j.bcp.2025.116787_b0705","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.111452","article-title":"Screening of SIRT6 inhibitors and activators: a novel activator has an impact on breast cancer cells","volume":"138","author":"Tenhunen","year":"2021","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bcp.2025.116787_b0710","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/md15060190","article-title":"The identification of a SIRT6 activator from brown algae fucus distichus","volume":"15","author":"Rahnasto-Rilla","year":"2017","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.bcp.2025.116787_b0715","doi-asserted-by":"crossref","first-page":"18355","DOI":"10.1074\/jbc.RA120.014883","article-title":"Nitro-fatty acids as activators of hSIRT6 deacetylase activity","volume":"295","author":"Carre\u00f1o","year":"2020","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bcp.2025.116787_b0720","doi-asserted-by":"crossref","first-page":"10474","DOI":"10.1021\/acs.jmedchem.0c01183","article-title":"Discovery of potent small-molecule SIRT6 activators: structure-activity relationship and anti-pancreatic ductal adenocarcinoma activity","volume":"63","author":"Chen","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.116787_b0725","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrm.2016.93","article-title":"Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds","volume":"17","author":"Bonkowski","year":"2016","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bcp.2025.116787_b0730","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1002\/cbic.201600655","article-title":"Studies of the binding of modest modulators of the human enzyme, sirtuin 6, by STD NMR","volume":"18","author":"Bol\u00edvar","year":"2017","journal-title":"Chembiochem"},{"key":"10.1016\/j.bcp.2025.116787_b0735","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1021\/acs.biochem.5b00150","article-title":"Kinetic and structural basis for acyl-group selectivity and NAD(+) dependence in sirtuin-catalyzed deacylation","volume":"54","author":"Feldman","year":"2015","journal-title":"Biochemistry"},{"key":"10.1016\/j.bcp.2025.116787_b0740","doi-asserted-by":"crossref","first-page":"7498","DOI":"10.1039\/C4OB00860J","article-title":"Thiomyristoyl peptides as cell-permeable Sirt6 inhibitors","volume":"12","author":"He","year":"2014","journal-title":"Org. Biomol. Chem."},{"key":"10.1016\/j.bcp.2025.116787_b0570","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1021\/jm500487d","article-title":"Discovery of novel and selective SIRT6 inhibitors","volume":"57","author":"Parenti","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.116787_b0745","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1096\/fj.201601294R","article-title":"Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model","volume":"31","author":"Sociali","year":"2017","journal-title":"FASEB J."},{"key":"10.1016\/j.bcp.2025.116787_b0750","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ejmech.2015.08.024","article-title":"Quinazolinedione SIRT6 inhibitors sensitize cancer cells to chemotherapeutics","volume":"102","author":"Sociali","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2025.116787_b0755","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1186\/s12974-020-01906-1","article-title":"Sirt6 inhibition delays the onset of experimental autoimmune encephalomyelitis by reducing dendritic cell migration","volume":"17","author":"Ferrara","year":"2020","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.bcp.2025.116787_b0575","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.735044","article-title":"Sirtuin modulators in cellular and animal models of human diseases","volume":"12","author":"Hong","year":"2021","journal-title":"Front. Pharmacol."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225000498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295225000498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T12:13:40Z","timestamp":1745842420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295225000498"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":143,"alternative-id":["S0006295225000498"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116787","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Potential of SIRT6 modulators in targeting molecular pathways involved in cardiovascular diseases and their treatment-A comprehensive review","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2025.116787","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"116787"}}